Corporate News     03-Sep-22
Board of Suven Pharmaceuticals recommends special dividend
Of Rs 5 per share
Suven Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 2 September 2022, inter alia, have recommended the special dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.
Previous News
  Suven Pharmaceuticals standalone net profit declines 31.49% in the September 2022 quarter
 ( Results - Announcements 08-Nov-22   13:36 )
  Suven Pharmaceuticals postpones board meeting
 ( Corporate News - 22-May-24   14:26 )
  Volumes soar at Garware Technical Fibres Ltd counter
 ( Hot Pursuit - 26-Dec-22   11:00 )
  Suven Pharmaceuticals to announce Quarterly Result
 ( Corporate News - 02-Feb-22   15:54 )
  Suven Pharma to manufacture anti-covid drugs Molnupiravir and 2-DG
 ( Corporate News - 10-Jun-21   17:27 )
  Zen Technologies Ltd leads gainers in 'A' group
 ( Hot Pursuit - 02-Mar-24   12:00 )
  Board of Suven Pharmaceuticals approves scheme of amalgamation
 ( Corporate News - 29-Feb-24   18:53 )
  Suven Pharmaceuticals consolidated net profit rises 30.91% in the September 2021 quarter
 ( Results - Announcements 06-Nov-21   14:43 )
  Board of Suvan Pharmaceuticals recommends special dividend
 ( Corporate News - 09-Feb-22   11:24 )
  Suven Pharmaceuticals consolidated net profit declines 25.70% in the September 2022 quarter
 ( Results - Announcements 08-Nov-22   13:39 )
  Suven Pharma climbs 15% in two days on merger plan
 ( Hot Pursuit - 02-Mar-24   12:25 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top